Vita Life Sciences Ltd.
Vita Life Sciences’ core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia.
See below for the Latest Vita Life Sciences Ltd. News, Analysis, Profit Results, Share Price Information, and Commentary. Singapore Business Review offers comprehensive coverage of breaking news and issues as they relate to Vita Life Sciences Ltd.
Read Here
Advertise
Sign Up
![[Singapore Business Review] Report on the Asian Business Channel](https://www.cmgassets.com/s3fs-public/styles/video_thumbnail/public/2026-10/full-show-thumbnail_1.png.webp?VersionId=bJbrT_JKOuMWBnf7YkmsWjOSWIXddSvY&itok=zWuxHRNG)
Commentary
In Asia, fintech leaders must compete on credibility
F1 on a gravel road: Why AI is still stuck in first gear
Why AI blocklists give Singapore firms a false sense of security
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia
Rethinking fleet ownership in a changing business landscape
Beyond the chips: The materials behind Singapore’s AI infrastructure
How homegrown brands are redefining premium in Asia
AI in hospitality: Where should Singapore’s F&B operators draw the line?
Do Singapore workplaces mistake silence for leadership?
AI as the new competitive advantage for Singapore’s small retailers